The fraction 1 and V protein antigens of Yersinia pestis activate dendritic cells to induce primary T cell responses

Clinical and Experimental Immunology

Volumn 149, Issue 3, 2007, Pages 561-569

  Kingston, R ^a   Burke, F ^a   Robinson, J H ^b   Bedford, P A ^a   Jones, S M ^c,d   Knight, S C ^a   Williamson, E D ^e  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c Public Health Agency of Canada   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

^e DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

Dendritic cells; rF1; rV; Yersinia pestis

Indexed keywords

ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 4; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN F1; VIRUS PROTEIN V;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BONE MARROW; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DOSE RESPONSE; EX VIVO STUDY; FEMALE; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; SPLEEN; SUPERNATANT; T LYMPHOCYTE; YERSINIA PESTIS;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELL PROLIFERATION; CYTOKINES; DENDRITIC CELLS; FEMALE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; PORE FORMING CYTOTOXIC PROTEINS; SPLEEN; T-LYMPHOCYTES; YERSINIA PESTIS;

EID: 34547912876     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03452.x     Document Type: Article

References (50)

1. Achtman M, Zurth K, Morelli G, Torrea G, Guiyoule A, Carniel E. Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc Natl Acad Sci USA 1999 96 : 14043 8.
2. Perry RD, Fetherston JD. Yersinia pestis - etiologic agent of plague. Clin Microbiol Rev 1997 10 : 35 66.
3. Brubaker RR. Factors promoting acute and chronic diseases caused by yersiniae. Clin Microbiol Rev 1991 4 : 309 24.
4. Parkhill J, Wren BW, Thomson NR et al. Genome sequence of Yersinia pestis, the causative agent of plague. Nature 2001 413 : 523 7.
5. Prentice MB, James KD, Parkhill J et al. Yersinia pestis pFra shows biovar-specific differences and recent common ancestry with a Salmonella enterica serovar Typhi plasmid. J Bacteriol 2001 183 : 2586 94.
6. Galyov EE, Smirnov OY, Karlishev AV et al. Nucleotide sequence of the Yersinia pestis gene encoding F1 antigen and the primary structure of the protein. FEBS Lett 1990 277 : 230 2.
7. Cornelis GR. The yersinia Ysc-Yop 'type III' weaponry. Nat Rev Mol Cell Biol 2002 3 : 742 52.
8. Cornelis GR, Wolf-Watz H. The yersinia Yop virulon: a bacterial system for subverting eukaryotic cells. Mol Microbiol 1997 23 : 861 7.
9. Mota LJ, Cornelis GR. The bacterial injection kit: type III secretion systems. Ann Med 2005 37 : 234 49.
10. Viboud GI, Bliska JB. Yersinia outer proteins: role in modulation of host cell signalling responses and pathogenesis. Annu Rev Microbiol 2005 59 : 69 89.
11. Pettersson J, Holmstrom A, Hill J et al. The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation. Mol Microbiol 1999 32 : 961 76.
12. Mueller CA, Broz P, Muller SA et al. The V-antigens of Yersinia forms a distinct structure at the tip of injectisome needles. Science 2005 310 : 674 6.
13. Congleton YHK, Wulff CR, Kerschen EJ, Straley SC. Mice naturally resistant to Yersinia pestisΔpgm strains commonly used in pathogenicity studies. Infect Immun 2006 74 : 6501 4.
14. Kerschen EJ, Cohen DA, Kaplan AM, Straley SC. The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infect Immun 2004 72 : 4589 602.
15. Palmer LE, Hobbie S, Galan JE, Bliska JB. YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-α production and downregulation of the MAP kinases p38 and JNK. Mol Microbiol 1998 27 : 953 65.
16. Ruckdsechel K, Harb S, Rogegnkamp A et al. Yersinia enterocolitica impairs activation of transcription factor NF-kappa B: involvement in the induction of programmed cell death and in the suppression of the macrophage tumour necrosis factor alpha production. J Exp Med 1998 187 : 1069 79.
17. Zauberman A, Cohen S, Mamroud E et al. Interaction of Yersinia pestis with macrophages: limitations in YopJ-dependent apoptosis. Infect Immun 2006 74 : 3239 50.
18. Velan B, Bar-Haim E, Zauberman A, Mamroud E, Shafferman A, Cohen S. Discordance in the effects of Yersinia pestis on the dendritic cell functions manifested by induction of maturation and paralysis of migration. Infect Immun 2006 74 : 6365 76.
19. Lukaszewski RA, Kenny DJ, Taylor RDGC, Rees Hartley MG, Oyston PCF. Pathogenesis of Yersinia pestis infection in Balb/c mice: effects on host macrophages and neutrophils. Infect Immun 2005 73 : 7142 50.
20. Marketon MM, DePaolo RW, DeBord KL, Jabri B, Schneewind O. Plague bacteria target immune cells during infection. Science 2005 309 : 1739 41.
21. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998 392 : 245 52.
22. Kalinski P, Hilkens CM, Wierenga EA, Kapsenberg ML. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today 1999 20 : 561 7.
23. Konecny P, Stagg AJ, Jebbari H, English N, Davidson RN, Knight SC. Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12 p40 and stimulate primary T cell proliferation in vitro. Eur J Immunol 1999 29 : 1803 11.
24. Macatonia SE, Taylor PM, Knight SC, Askonas BA. Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J Exp Med 1989 169 : 1255 64.
25. d'Ostiani CF, Del Sero G, Bacci A et al. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med 2000 191 : 1661 74.
26. Sousa CR, Hieny S, Scharton-Kersten T et al. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J Exp Med 1997 186 : 1819 29.
27. Powell BS, Andrews GP, Enama JT et al. Design and testing for a non-tagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague. Biotechnol Prog 2005 21 : 1490 510.
28. Williamson ED, Flick-Smith HC, Lebutt CS et al. Human immune response to a plague vaccine comprising recombinant F1 and rV antigens. Infect Immun 2005 73 : 3598 608.
29. Williamson ED. Plague vaccine research and development. J Appl Micro 2001 91 : 606 8.
30. Carr S, Miller J, Leary SEC, Bennett AM, Ho A, Williamson ED. 2000. Expression of a recombinant form of the V antigen of Yersinia pestis, using three different expression systems. Vaccine 2000 18 : 153 9.
31. Jones SM, Griffin KF, Hodgson I, Williamson ED. Protective efficacy of a fully recombinant plague vaccine in the guinea pig. Vaccine 2003 21 : 3912 8.
32. Knight SC, Iqball S, Roberts MS, Macatonia S, Bedford PA. Transfer of antigen between dendritic cells in the stimulation of primary T cell proliferation. Eur J Immunol 1998 28 : 1636 44.
33. Kelleher P, Maroof A, Knight SC. Retrovirally induced switch from production of IL-12 to IL-4 in dendritic cells. Eur J Immunol 1999 29 : 2309 18.
34. Maroof A, Penny M, Kingston R, Murray C, Islam S, Bedford PA, Knight SC. Interleukin-4 can induce interleukin-4 production in dendritic cells. Immunol 2006 117 : 271 9.
35. Knight SC. Lymphocyte proliferation assays. In : Klaus GGB, ed. Lymphocytes: a practical approach. Oxford : IRL Press, 1987 : 189 207.
36. Ewen C, Baca-Estrada ME. Evaluation of interleukin-4 concentration by ELISA is influenced by the consumption of IL-4 by cultured cells. J Interferon Cytokine Res 2001 21 : 39 43.
37. Bedford P, Garner K, Knight SC. MHC class II molecules transferred between allogeneic dendritic cells stimulate primary mixed leukocyte reactions. Int Immunol 1999 11 : 1739 44.
38. Knight SC, Bedford PA. Dendritic cell/dendritic cell interaction. In : Thompson AW, Lotze MT, eds. Dendritic cells: biology and clinical applications, 2nd edn. London : Academic Press, 2001 : 333 43.
39. Bedford PA, Clarke LB, Hastings GZ, Knight SC. Primary proliferative responses to peptides of HIV Gag p24. J Acq Immune Defic Syndr Hum Retrovirol 1997 14 : 301 6.
40. Van Den Bogaerde JB, Kamm MA, Knight SC. Immune sensitization to food and bacteria in Crohn's disease. Gastroenterol 1998 114 : G3839.
41. Allan RS, Waithman J, Bedoui S et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006 25 : 153 62.
42. Andre F, Chaput N, Schartz NE et al. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J Immunol 2004 172 : 2126 36.
43. Ciavarra RP, Greene AR, Horeth DR, Buhrer K, Van Rooijen N, Tedeschi B. Antigen processing of vesicular stomatitis virus in situ. Interdigitating dendritic cells present viral antigens independent of marginal dendritic cells but fail to prime CD4(+) and CD8(+) T cells. Immunology 2000 101 : 512 20.
44. Dolan BP, Gibbs KD Jr., Ostrand-Rosenberg S. Tumor-specific CD4+ T cells are activated by 'cross-dressed' dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines. J Immunol 2006 176 : 1447 55.
45. Smith AL, de St Groth BF. Antigen-pulsed CD8alpha+ dendritic cells generate an immune response after subcutaneous injection without homing to the draining lymph node. J Exp Med 1999 189 : 593 8.
46. Thery C, Regnault A, Garin J et al. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol 1999 147 : 599 610.
47. Knight SC, Fryer PR, Griffiths S, Harding B. Class II histocompatibility antigens on human dendritic cells. Immunol 1987 61 : 21 7.
48. Zitvogel L, Regnault A, Lozier A et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 1998 4 : 594 600.
49. Elvin SJ, Healey GD, Westwood A, Eyles JE, Williamson ED. Protection against heterologous B. pseudomallei strains using dendritic cell immunisation. Infect Immun 2006 74 : 1706 11.
50. Healey GD, Elvin SJ, Williamson ED. Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance post infection. Infect Immun 2005 73 : 5945 51.